Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell recognition in chronic beryllium disease.

Massimo Amicosante1, Andrew P Fontenot

  • 1Department of Internal Medicine, University of Rome "Tor Vergata", Rome, Italy.

Clinical Immunology (Orlando, Fla.)
|May 16, 2006
PubMed
Summary

Chronic beryllium disease (CBD) involves beryllium-specific T cells attacking the lungs. Genetic factors, like HLA-DP alleles, influence CBD development and severity in exposed workers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo-Controlled, Phase III Trial.

Allergy·2026
Same author

Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHC II CAR-T cell-treated mice.

JCI insight·2026
Same author

Interleukin-1 signaling and CD4<sup>+</sup> T cells control B cell recruitment to the lungs in chronic beryllium disease.

Frontiers in immunology·2025
Same author

Occupational interstitial lung diseases.

Journal of internal medicine·2023
Same author

Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced by <i>Saccharopolyspora rectivirgula</i>.

American journal of physiology. Lung cellular and molecular physiology·2022
Same author

Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease.

JCI insight·2022

Area of Science:

  • Immunology
  • Occupational Health
  • Genetics

Background:

  • Chronic beryllium disease (CBD) is a granulomatous lung disorder resulting from occupational beryllium exposure.
  • CBD is characterized by the accumulation of beryllium-specific CD4(+) T cells in the lungs.
  • Genetic susceptibility, particularly specific HLA-DP alleles, plays a role in CBD development.

Purpose of the Study:

  • To elucidate the immunological mechanisms underlying chronic beryllium disease.
  • To investigate the role of HLA-DP alleles in beryllium presentation to T cells.
  • To establish CBD as a model for immune-mediated organ destruction.

Main Methods:

  • Analysis of T cell accumulation and cytokine secretion in CBD patients.
  • Investigation of HLA-DP allele association with beryllium susceptibility.
  • Correlating circulating T cells with disease severity.

Main Results:

  • Beryllium-specific CD4(+) T cells accumulate in the lungs of affected individuals.
  • Specific HLA-DP alleles facilitate beryllium binding and presentation to T cells.
  • Circulating beryllium-specific CD4(+) T cells correlate directly with lymphocytic alveolitis severity.

Conclusions:

  • CBD pathogenesis involves beryllium-specific CD4(+) T cells and susceptible HLA-DP alleles.
  • CBD serves as a valuable model for understanding autoimmune diseases with unknown antigens.
  • Findings have implications for autoimmune disease research, particularly those with inaccessible target organs.

Related Experiment Videos